Insulin Resistance, Adiponectin, Cytokines in NASH: Which is the Best Target to Treat?

dc.contributor.author	Larter, Claire
dc.contributor.author	Farrell, Geoffrey
dc.date.accessioned	2015-12-10T22:39:50Z
dc.date.issued	2006
dc.date.updated	2015-12-09T10:54:48Z
dc.identifier.issn	0168-8278
dc.identifier.uri	http://hdl.handle.net/1885/57357
dc.publisher	Elsevier
dc.source	Journal of Hepatology
dc.subject	Keywords: acyl coenzyme A; adiponectin; ceramide; cytokine; diacylglycerol; fatty acid; glitazone derivative; glucose; I kappa B kinase beta; immunoglobulin enhancer binding protein; insulin; insulin receptor substrate 1; insulin receptor substrate 2; interleukin 6
dc.title	Insulin Resistance, Adiponectin, Cytokines in NASH: Which is the Best Target to Treat?
dc.type	Journal article
local.bibliographicCitation.issue	2
local.bibliographicCitation.lastpage	261
local.bibliographicCitation.startpage	253
local.contributor.affiliation	Larter, Claire, College of Medicine, Biology and Environment, ANU
local.contributor.affiliation	Farrell, Geoffrey, College of Medicine, Biology and Environment, ANU
local.contributor.authoruid	Larter, Claire, u4367140
local.contributor.authoruid	Farrell, Geoffrey, u4028700
local.description.embargo	2037-12-31
local.description.notes	Imported from ARIES
local.identifier.absfor	110307 - Gastroenterology and Hepatology
local.identifier.ariespublication	u4167262xPUB397
local.identifier.citationvolume	44
local.identifier.doi	10.1016/j.jhep.2005.11.030
local.identifier.scopusID	2-s2.0-30444461216
local.type.status	Published Version

Downloads

Now showing 1 - 1 of 1